A randomized control trial to assess the impact of vitamin D supplementation compared to placebo on vascular stiffness in chronic kidney disease patients.
Open Access
- 7 November 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Cardiovascular Disorders
- Vol. 14 (1), 156
- https://doi.org/10.1186/1471-2261-14-156
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney DiseaseJAMA, 2012
- The VITamin D and OmegA-3 TriaL (VITAL): Rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular diseaseContemporary Clinical Trials, 2012
- Low 25-Hydroxyvitamin D Levels and Mortality in Non–Dialysis-Dependent CKDAmerican Journal of Kidney Diseases, 2011
- Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trialThe Lancet, 2010
- Vitamin D compounds for people with chronic kidney disease not requiring dialysisEmergencias, 2009
- Rosuvastatin and Cardiovascular Events in Patients Undergoing HemodialysisThe New England Journal of Medicine, 2009
- A Comparison of Sevelamer and Calcium-Based Phosphate Binders on Mortality, Hospitalization, and Morbidity in Hemodialysis: A Secondary Analysis of the Dialysis Clinical Outcomes Revisited (DCOR) Randomized Trial Using Claims DataAmerican Journal of Kidney Diseases, 2008
- Vitamin D Supplementation and Total MortalityA Meta-analysis of Randomized Controlled TrialsArchives of Internal Medicine, 2007
- Vitamin D DeficiencyThe New England Journal of Medicine, 2007
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationThe New England Journal of Medicine, 2004